Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 20.07 CNY 2.14% Market Closed
Updated: May 20, 2024

Relative Value

The Relative Value of one Hualan Biological Engineering Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 20.07 CNY, Hualan Biological Engineering Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hualan Biological Engineering Inc Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
58
Median 3Y
8.9
Median 5Y
11
Industry
8.2
Forward
5.9
vs History
85
vs Industry
7
Median 3Y
33.4
Median 5Y
35.9
Industry
26.1
Forward
20.9
vs History
47
vs Industry
5
Median 3Y
33.5
Median 5Y
35.2
Industry
24.8
vs History
34
vs Industry
3
Median 3Y
47.7
Median 5Y
48.1
Industry
23.4
vs History
88
vs Industry
30
Median 3Y
3.9
Median 5Y
6.4
Industry
2.6
vs History
87
vs Industry
50
Median 3Y
8.4
Median 5Y
10.2
Industry
7.4
Forward
5.3
vs History
87
vs Industry
41
Median 3Y
12.3
Median 5Y
16.4
Industry
9.1
vs History
84
vs Industry
7
Median 3Y
25.9
Median 5Y
29
Industry
4.6
Forward
12.9
vs History
84
vs Industry
7
Median 3Y
25.9
Median 5Y
29
Industry
4.4
Forward
14.1
vs History
52
vs Industry
6
Median 3Y
31.1
Median 5Y
34
Industry
6.4
vs History
22
vs Industry
2
Median 3Y
68.7
Median 5Y
68.1
Industry
3.8
vs History
88
vs Industry
43
Median 3Y
3.5
Median 5Y
6.3
Industry
4.9

Multiples Across Competitors

Competitors Multiples
Hualan Biological Engineering Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hualan Biological Engineering Inc
SZSE:002007
36.6B CNY 7 26.3 18.8 18.8
US
Abbvie Inc
NYSE:ABBV
291B USD 5.4 49 13.7 21.1
US
Amgen Inc
NASDAQ:AMGN
167.8B USD 5.7 44.7 18.8 31
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.5B USD 11.3 28.8 24.1 25.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
108.7B USD 8.3 28.1 22.7 25.2
AU
CSL Ltd
ASX:CSL
134.3B AUD 6.3 36.4 22 27.2
US
Gilead Sciences Inc
NASDAQ:GILD
84.7B USD 3.1 174.7 8.8 11.6
US
Moderna Inc
NASDAQ:MRNA
54B USD 10.5 -9.1 -10.1 -9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.7B USD 3.5 28.9 14.7 18.4
KR
Celltrion Inc
KRX:068270
38.7T KRW 17.8 72.3 44.3 61

See Also

Discover More